Cargando…

Restoring autophagic function: a case for type 2 diabetes mellitus drug repurposing in Parkinson’s disease

Parkinson’s disease (PD) is a predominantly idiopathic pathological condition characterized by protein aggregation phenomena, whose main component is alpha-synuclein. Although the main risk factor is ageing, numerous evidence points to the role of type 2 diabetes mellitus (T2DM) as an etiological fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greco, Marco, Munir, Anas, Musarò, Debora, Coppola, Chiara, Maffia, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654753/ https://www.ncbi.nlm.nih.gov/pubmed/38027497 http://dx.doi.org/10.3389/fnins.2023.1244022

Ejemplares similares

Blood Metabolite Profiling of Antarctic Expedition Members: An (1)H NMR Spectroscopy-Based Study
por: Del Coco, Laura, et al.
Publicado: (2023)

Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience
por: Stott, Simon R. W., et al.
Publicado: (2021)

Parkinson’s disease and diabetes mellitus: common mechanisms and treatment repurposing
por: Labandeira, Carmen M., et al.
Publicado: (2022)

Copper Dependent Modulation of α-Synuclein Phosphorylation in Differentiated SHSY5Y Neuroblastoma Cells
por: Greco, Marco, et al.
Publicado: (2021)

Drug Repurposing in the Treatment of Traumatic Brain Injury
por: Ghiam, Michael K., et al.
Publicado: (2021)

Bioenergetics and Autophagic Imbalance in Patients-Derived Cell Models of Parkinson Disease Supports Systemic Dysfunction in Neurodegeneration
por: González-Casacuberta, Ingrid, et al.
Publicado: (2019)

Drug repurposing strategies of relevance for Parkinson’s disease
por: Fletcher, Edward J. R., et al.
Publicado: (2021)

Involvement of Autophagic Pathway in the Progression of Retinal Degeneration in a Mouse Model of Diabetes
por: Piano, Ilaria, et al.
Publicado: (2016)

Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
por: Jung, Yoo Jin, et al.
Publicado: (2021)

Drug repurposing using meta-analysis of gene expression in Alzheimer’s disease
por: Jang, Ha Young, et al.
Publicado: (2022)

Caloric Restriction Alleviates CFA-Induced Inflammatory Pain via Elevating β-Hydroxybutyric Acid Expression and Restoring Autophagic Flux in the Spinal Cord
por: Liu, Chang, et al.
Publicado: (2022)

Fingolimod and Diabetic Retinopathy: A Drug Repurposing Study
por: Gesualdo, Carlo, et al.
Publicado: (2021)

Repurposing Drugs for Diabetes Mellitus as Potential Pharmacological Treatments for Sarcopenia – A Narrative Review
por: Witham, Miles D., et al.
Publicado: (2023)

Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?
por: Carboni, Ezio, et al.
Publicado: (2021)

Conventional protein kinase C in the brain: repurposing cancer drugs for neurodegenerative treatment?
por: Lordén, Gema, et al.
Publicado: (2021)

Mitohormesis and autophagic balance in Parkinson disease
por: Juarez-Flores, Diana Luz, et al.
Publicado: (2019)

Repurposing Pimavanserin, an Anti-Parkinson Drug for Pancreatic Cancer Therapy
por: Ramachandran, Sharavan, et al.
Publicado: (2020)

The role of autophagic kinases in regulation of axonal function
por: Berth, Sarah H., et al.
Publicado: (2022)

Drug repurposing for the treatment of glioblastoma multiforme
por: Abbruzzese, Claudia, et al.
Publicado: (2017)

Modeling Parkinson’s disease in LRRK2 rodents
por: Domenicale, Chiara, et al.
Publicado: (2023)

Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges
por: Agostini, Francesco, et al.
Publicado: (2021)

Deficiency of prion protein induces impaired autophagic flux in neurons
por: Shin, Hae-Young, et al.
Publicado: (2014)

Integrated Computational Analysis of Genes Associated with Human Hereditary Insensitivity to Pain. A Drug Repurposing Perspective
por: Lötsch, Jörn, et al.
Publicado: (2017)

COVID-19: Sleep, Circadian Rhythms and Immunity – Repurposing Drugs and Chronotherapeutics for SARS-CoV-2
por: Giri, Allan, et al.
Publicado: (2021)

Editorial: The challenges of drug repurposing in diseases related to chronic inflammation
por: Collotta, Debora, et al.
Publicado: (2023)

Iron deposition heterogeneity in extrapyramidal system assessed by quantitative susceptibility mapping in Parkinson’s disease patients with type 2 diabetes mellitus
por: Li, Wanyao, et al.
Publicado: (2022)

Teaching the basics of repurposing mitochondria-targeted drugs: From Parkinson's disease to cancer and back to Parkinson's disease
por: Kalyanaraman, Balaraman
Publicado: (2020)

Ofloxacin as a Disruptor of Actin Aggresome “Hirano Bodies”: A Potential Repurposed Drug for the Treatment of Neurodegenerative Diseases
por: Pathak, Samridhi, et al.
Publicado: (2020)

Kinematics of the Reach-to-Grasp Movement in Vascular Parkinsonism: A Comparison with Idiopathic Parkinson’s Disease Patients
por: Parma, Valentina, et al.
Publicado: (2014)

Dopamine induces the accumulation of insoluble prion protein and affects autophagic flux
por: da Luz, Marcio H. M., et al.
Publicado: (2015)

Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson’s Disease
por: Palmas, Maria Francesca, et al.
Publicado: (2022)

Intensive exercise ameliorates motor and cognitive symptoms in experimental Parkinson’s disease restoring striatal synaptic plasticity
por: Marino, Gioia, et al.
Publicado: (2023)

Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease
por: Siani, Francesca, et al.
Publicado: (2017)

Celecoxib alleviates nonalcoholic fatty liver disease by restoring autophagic flux
por: Liu, Cong, et al.
Publicado: (2018)

Autophagic flux restoration enhances the antitumor efficacy of tumor infiltrating lymphocytes
por: Zhang, Chaoting, et al.
Publicado: (2022)

Degradation and Transmission of Tau by Autophagic-Endolysosomal Networks and Potential Therapeutic Targets for Tauopathy
por: Jiang, Shanya, et al.
Publicado: (2020)

Drug repurposing for reducing the risk of cataract extraction in patients with diabetes mellitus: integration of artificial intelligence-based drug prediction and clinical corroboration
por: Gao, Zhenxiang, et al.
Publicado: (2023)

Commentary: Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease
por: Park, Jin-Sung, et al.
Publicado: (2017)

Has Drug Repurposing Fulfilled Its Promise in Acute Myeloid Leukaemia?
por: Valli, Debora, et al.
Publicado: (2020)

Parkinson’s Disease Drug Development Since 1999: A Story of Repurposing and Relative Success
por: Boucherie, Deirdre M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g4iksddjv075lmarm7m07ndln9